Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nebivolol/valsartan combination for the treatment of hypertension: a review.

Future cardiology·2020
Same author

Chagas Cardiomyopathy in New Orleans and the Southeastern United States.

Ochsner journal·2016
Same author

Fixed-dose combination therapy of nebivolol and valsartan for the treatment of hypertension.

Expert review of cardiovascular therapy·2016
Same author

Stress Cardiomyopathy in the Setting of COPD Exacerbation.

Journal of investigative medicine high impact case reports·2016
Same author

Prehypertension: Defining the Transitional Phenotype.

Current hypertension reports·2015
Same author

Endothelial Progenitor Cells as a Biomarker for Transitional Phenotypes in Hypertension.

Journal of clinical hypertension (Greenwich, Conn.)·2015
Same journal

Fluid Flow Patterns Through Drainage Catheters: Clinical Observations in 99 Patients.

The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society·2019
Same journal

Radiology Case of the Month: TB or Not TB… That is the Question.

The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society·2017
Same journal

ECG Case of the Month: Wide-QRS Rhythm in a Man with a Clotted Dialysis Fistula.

The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society·2017
Same journal

Clinical Case of the Month:: Abdominal Pain in a 39-year-old Man with Recent International Travel.

The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society·2017
Same journal

Postpartum Coronary Arterial Spasm.

The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society·2017
Same journal

An Elderly Man with a Swollen Knee,Significant Ecchymosis, and Minimal Knee Pain.

The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society·2017
See all related articles

Related Experiment Video

Updated: Jun 10, 2026

Organ Ischemia-Reperfusion Injury by Simulating Hemodynamic Changes in Rat Liver Transplant Model
10:07

Organ Ischemia-Reperfusion Injury by Simulating Hemodynamic Changes in Rat Liver Transplant Model

Published on: March 6, 2021

Atorvastatin induced multiple organ failure.

Ramprasad Kandavar1, Gary E Sander

  • 1Department of Internal Medicine, Tulane University School of Medicine, New Orleans, USA.

The Journal of the Louisiana State Medical Society : Official Organ of the Louisiana State Medical Society
|July 30, 2010
PubMed
Summary
This summary is machine-generated.

A fatal drug interaction between atorvastatin and verapamil may have caused multiple organ failure in a patient with common comorbidities. This case highlights the critical need to monitor for adverse drug events, especially in patients with diabetes and cardiovascular disease.

Area of Science:

  • Pharmacology
  • Internal Medicine
  • Toxicology

Background:

  • A 71-year-old woman with diabetes, coronary artery disease, hypertension, and hyperlipidemia presented with symptoms including nausea, vomiting, myalgia, weakness, and dark urine.

Related Experiment Videos

Last Updated: Jun 10, 2026

Organ Ischemia-Reperfusion Injury by Simulating Hemodynamic Changes in Rat Liver Transplant Model
10:07

Organ Ischemia-Reperfusion Injury by Simulating Hemodynamic Changes in Rat Liver Transplant Model

Published on: March 6, 2021

  • Her medication regimen included atorvastatin and verapamil.